SEC Form 4 · accession 0000899243-18-023645
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicolas Barthelemy
Director
Period of report
Aug 29, 2018
Accepted (ET)
Aug 31, 2018 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 29, 2018 | M | 2,434 | $38.76 | A | 8,774 | D | |
| Common Stock | Aug 29, 2018 | M | 1,992 | $41.19 | A | 10,766 | D | |
| Common StockF1 | Aug 29, 2018 | S | 6,580 | $54.4371 | D | 4,186 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $38.76 | Aug 29, 2018 | M | 2,434 | D | — | May 18, 2027 | Common Stock | 2,434 | 0 | D |
| Stock Option (Right to Buy)F2 | $41.19 | Aug 29, 2018 | M | 1,992 | D | — | May 21, 2025 | Common Stock | 1,992 | 0 | D |
Explanation of responses
- F1$54.4371 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.39 to $54.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2This option is currently exercisable.